SCHEMBL5166407

SCHEMBL5166407

Cc1cccc2c1c(N)c(C(=O)N(C)c1ccccc1)c(=O)n2C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ PGR P06401 1/20 0.58
▸ SRC P12931 1/20 0.50
▸ HDAC4 P56524 1/20 0.46
▸ MAP3K5 Q99683 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ PABPC1 P11940 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ PRMT5 O14744 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5167471 0.87 MEN1 (0.57) MEN1KMT2APGRSRCHDAC4
SCHEMBL5167153 0.87 MEN1 (0.70) MEN1KMT2APGRSRCHDAC4
SCHEMBL5165191 0.86 KMT2A (0.58) MEN1KMT2APGRSRCHDAC4
SCHEMBL5164479 0.86 MEN1 (0.58) MEN1KMT2APGRSRCHDAC4
SCHEMBL5166909 0.85 HDAC4 (0.61) MEN1KMT2APGRSRCHDAC4
SCHEMBL5165239 0.84 MEN1 (0.56) MEN1KMT2APGRSRCHDAC4
SCHEMBL10671150 0.83 KMT2A (0.74) MEN1KMT2APGRSRCHDAC4
SCHEMBL5180583 0.81 MEN1 (0.56) MEN1KMT2APGRSRCHDAC4
SCHEMBL10675112 0.81 KMT2A (0.68) MEN1KMT2APGRSRCHDAC4
SCHEMBL17816198 0.78 MEN1 (0.71) MEN1KMT2APGRSRCHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP claimed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 — — EP claimed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US claimed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 — — WO claimed
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP disclosed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 — — EP disclosed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 — — WO disclosed
Send feedback